openPR Logo
Press release

Lymphocyte Activation Gene 3 Protein Market- Size, Share, Outlook, and Forecast till 2026

08-30-2018 04:39 PM CET | Health & Medicine

Press release from: Worldwide Market Reports

Lymphocyte Activation Gene 3 Protein Market- Size, Share,

Lymphocyte-activation gene 3, also known as LAG-3, is a protein that is has diverse biological effects on the functioning of T cells. This protein was first discovered in 1990. LAG-3 is an immune checkpoint receptor, and is thus used as the target of various drug development programs.
Increasing prevalence of chronic diseases such as cancer and autoimmune diseases such as AIDS are expected to increase the demand for treatment measures. This in turn, is expected to increase demand for lymphocyte-activation gene 3 protein, thus boosting growth of the lymphocyte-activation gene 3 market. Increasing number of pharmaceutical companies are seeking to develop new treatments for cancer and autoimmune disorders is expected to boost growth of the Lymphocyte-activation gene 3 protein market.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/196105

Prima BioMed Ltd is a biotechnology company that is engaged in research, development, and commercialization of licensed medical biotechnology. It is also focused on development of immunotherapeutic products. The Company operates through Cancer Immunotherapy segment with its core technologies based on the Lymphocyte-activation gene 3 (LAG-3) immune control mechanism, which is involved in regulation of the T cell immune response.
The lymphocyte-activation gene 3 market is gaining significant traction, owing to increasing research and development activities by various key players in the market.

Get Best Discount On This Report: https://www.worldwidemarketreports.com/discount/196105

F-star, a clinical-stage biopharmaceutical company developing novel bispecific antibodies—announced successful dosing of the first patient with FS118 in a Phase I clinical trial. FS118 is a first-in-class bispecific antagonist simultaneously targeting LAG-3 (Lymphocyte-Activation Gene 3) and PD-L1 (Programmed Death-Ligand 1), two immune checkpoint molecules involved in tumor growth through attenuation of immune surveillance. FS118 showed potent anti-cancer activity in preclinical models, as recently presented by F-star at the 2018 AACR meeting.

In March 2015, a breakthrough in immunotherapy was recorded when the FDA approved Nivolumab as a second line treatment for metastatic lung squamous carcinoma. Nivolumab was previously known to be indicated for use among patients suffering from melanoma that is either not resectable or had not responded to other therapies.6, 7, 8, 10, not all PD‐1 or PD‐L1 positive patients show positive outcomes through this treatment of anti‐PD‐1 or PD‐L1 monoclonal antibody.

In 2014, GSK successfully was able to receive positive outcomes from its product GSK2831781, an anti LAG-3 drug, which proved to demonstrate positive results among healthy people and patients suffering from plaque psoriasis.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lymphocyte Activation Gene 3 Protein Market- Size, Share, Outlook, and Forecast till 2026 here

News-ID: 1212911 • Views:

More Releases from Worldwide Market Reports

Virtual Group Counseling Market Growth Opportunities: Insights from Latest Research Report Forecast 2024 to 2031 |BetterHelp, Talkspace, 7 Cups, Online-Therapy.com
Virtual Group Counseling Market Growth Opportunities: Insights from Latest Resea …
The Virtual Group Counseling Market Trends Overview 2024-2031: A new Report by Worldwide Market Reports, titled "Virtual Group Counseling Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Virtual Group Counseling market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts,
Travel Pass Subscription Market Trends, Key Players Analysis, Regional Trends, Competitive Landscape, and Industry Potential by 2031 |AAA, Blade Plus, Global Entry, Going
Travel Pass Subscription Market Trends, Key Players Analysis, Regional Trends, C …
The Travel Pass Subscription Market research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Travel Pass Subscription industry along with various other factors over the predicted period 2024-2031. The report on the Travel Pass Subscription market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.
Intelligent Multi-Purpose Arena Market Booming Worldwide from 2024 to 2031 |IBM, Ericsson, Intel, NTT, Tech Mahindra
Intelligent Multi-Purpose Arena Market Booming Worldwide from 2024 to 2031 |IBM, …
The Intelligent Multi-Purpose Arena Market Trends Overview 2024-2031: A new Report by Worldwide Market Reports, titled "Intelligent Multi-Purpose Arena Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Intelligent Multi-Purpose Arena market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts,
Nuclear Plant Safety Simulation Market Research Report: In-Depth Qualitative Insights, Industry Size, Explosive Growth Opportunity, Regional Analysis 2024-2031 |GSE Systems, L3Harris Technologies
Nuclear Plant Safety Simulation Market Research Report: In-Depth Qualitative Ins …
The Nuclear Plant Safety Simulation Market research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Nuclear Plant Safety Simulation industry along with various other factors over the predicted period 2024-2031. The report on the Nuclear Plant Safety Simulation market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels,

All 5 Releases


More Releases for Gene

Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Gene editing or Genome editing is
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product